Evidence map›Paper›PMID 32252720›Full record

Observational studyBMC psychiatry2020

Sleep quality improves during treatment with repetitive transcranial magnetic stimulation (rTMS) in patients with cocaine use disorder: a retrospective observational study.

Luis J Gómez Pérez, Stefano Cardullo, Nicola Cellini, Michela Sarlo, Tommaso Monteanni, Antonello Bonci, Alberto Terraneo, Luigi Gallimberti, Graziella Madeo

Registry-linked trialOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03733821 (Sleep Modifications in Patients With Cocaine Use Disorders Treated With Transcranial Magnetic Stimulation), which is not on this map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03733821 unknown statusnot on this map

Sleep Modifications in Patients With Cocaine Use Disorders Treated With Transcranial Magnetic Stimulation (TMS)

TypeobservationalSponsorFondazione Novella FrondaRan2015 to 2022Enrolled1,000ConditionsCocaine Use Disorder, Sleep DisturbanceArmsRepetitive Transcranial Magnetic Stimulation
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. At the intersection of sleep deficiency and opioid use: mechanisms and therapeutic opportunities.Translational research : the journal of laboratory and clinical medicine · 2021
    Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Luis J Gómez PérezNovella Fronda Foundation, Piazza Castello, 16 -, 35141, Padua, Italy.
Stefano CardulloNovella Fronda Foundation, Piazza Castello, 16 -, 35141, Padua, Italy.
Nicola CelliniDepartment of General Psychology, University of Padova, Padua, Italy.
Michela SarloDepartment of General Psychology, University of Padova, Padua, Italy.
Tommaso MonteanniPadova Neuroscience Center, University of Padova, Padua, Italy.
Antonello BonciGlobal Institutes on Addictions, Miami, FL, USA.
Alberto TerraneoNovella Fronda Foundation, Piazza Castello, 16 -, 35141, Padua, Italy.
Luigi GallimbertiNovella Fronda Foundation, Piazza Castello, 16 -, 35141, Padua, Italy.
Graziella MadeoNovella Fronda Foundation, Piazza Castello, 16 -, 35141, Padua, Italy. graziemadeo@gmail.com.
University of Padua · ITGlobal Institutes on Addictions · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSleep disturbance is a prominent and common complaint in people with cocaine use disorder (CUD), either during intake or withdrawal. Repetitive transcranial magnetic stimulation (rTMS) has shown promise as a treatment for CUD. Thus, we evaluated the relationship between self-perceived sleep quality and cocaine use pattern variables in outpatients with CUD undergoing an rTMS protocol targeted at the left dorsolateral prefrontal cortex.

methodsThis is a retrospective observational study including 87 patients diagnosed with CUD according to the DSM-5 criteria. Scores in Pittsburgh Sleep Quality Index (PSQI), Cocaine Craving Questionnaire (CCQ), Beck Depression Inventory-II (BDI-II), Self-rating Anxiety Scale (SAS), and Symptoms checklist 90-Revised (outcome used: Global Severity Index, GSI) were recorded at baseline, and after 5, 30, 60, and 90 days of rTMS treatment. Cocaine use was assessed by self-report and regular urine screens.

resultsSleep disturbances (PSQI scores > 5) were common in patients at baseline (mean ± SD; PSQI score baseline: 9.24 ± 3.89; PSQI > 5 in 88.5% of patients). PSQI scores significantly improved after rTMS treatment (PSQI score Day 90: 6.12 ± 3.32). Significant and consistent improvements were also seen in craving and in negative-affect symptoms compared to baseline. Considering the lack of a control group, in order to help the conceptualization of the outcomes, we compared the results to a wait-list group (n = 10). No significant improvements were observed in the wait-list group in any of the outcome measures.

conclusionsThe present findings support the therapeutic role of rTMS interventions for reducing cocaine use and accompanying symptoms such as sleep disturbance and negative-affect symptoms.

trial registrationClinicalTrials.gov.NCT03733821.

Indexed as

AdultCocaineCocaine-Related DisordersCravingFemaleHumansMaleMiddle AgedPrefrontal CortexRetrospective StudiesSleepSurveys and QuestionnairesTranscranial Magnetic StimulationTreatment OutcomeCocaineCocaine use disorder (CUD)CravingDorsolateral prefrontal cortex (DLPFC)Pittsburgh sleep quality index (PSQI)Repetitive Transcranial magnetic stimulation (rTMS)Sleep

Identifiers

PMID32252720
PMCPMC7137315
OpenAlexW3014330321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.